Abstract

In vivo harmonic generation microscopy (HGM) has been applied successfully in healthy human skin and can achieve a submicron resolution, similar to histopathologic examination, even at a penetration depth up to 270 μm. This study aims to investigate the clinical applicability of HGM imaging for differential diagnosis of nonmelanoma pigmented skin lesions. A total of 42 pigmented skin tumors, including pigmented basal cell carcinoma, melanocytic nevus, and seborrheic keratosis were evaluated by HGM ex vivo or in vivo. Based on the standard histopathologic characteristics, we established the corresponding HGM imaging criteria for each pigmented tumor. Diagnostic performance of HGM for differentiating nonmelanoma pigmented skin tumors was evaluated through the observers' direct general assessment (overall evaluation) or the presence of two imaging criteria with the highest sensitivity and specificity (major criteria evaluation). Our results show that, based on the direct general assessment, the sensitivity is 92% [95% confidence interval (CI): 67 to 97%] and the specificity is 96% (95% CI: 83 to 99%); by major criteria evaluation, 94% sensitivity (95% CI: 70 to 99%) and 100% specificity (95% CI: 87 to 100%) are achieved. Our study indicates that HGM serves as a promising histopathological examination tool for noninvasive differential diagnostics of nonmelanoma pigmented skin tumors.

Highlights

  • Because of the increasing prevalence of skin cancer, screening for malignant skin lesions has become a common prevention intervention for the general population

  • Due to the large variation of the appearance of pigmented skin tumors in clinical diagnosis, we focused on the differentiation of pigmented skin lesions in this study

  • Our results showed that the traditional histopathological features, such as monomorphous cell nests in nevocellular nevus, or peripheral palisading of tumor cells in basal cell carcinoma (BCC), could clearly be observed using harmonic generation microscopy (HGM)

Read more

Summary

Introduction

Because of the increasing prevalence of skin cancer, screening for malignant skin lesions has become a common prevention intervention for the general population. Given the large variation of the appearance and behavior of pigmented skin tumors, diagnosis by the naked eye is certainly insufficient to identify skin cancers.[5,6] the timely and precise detection of malignant pigmented tumors is strongly required to ease patient anxiety and improve clinical outcomes

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call